Form 4: Allovir CEO Diana Brainard Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Allovir's CEO, Diana Brainard, sold 1,493 shares of common stock on October 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On October 3, 2024, Diana Brainard, the CEO of Allovir, Inc., sold 1,493 shares of Allovir's common stock.
- The sale was executed at a price of $0.8148 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Brainard directly owns 752,430 shares of Allovir's common stock.
Sentiment
Score: 6
Explanation: The document describes a routine transaction (selling shares to cover taxes). It's neutral, not particularly positive or negative for the company's outlook.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and are generally not indicative of a negative outlook on the company's future.
Key Dates
| Date | Description |
|---|---|
| 10/03/2024 | Date of stock sale transaction |
| 10/04/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.